The volume of accelerated offerings reaches a record level as existing shareholders secure profits and investors are attracted to the fact that these deals come with far less market risk than IPOs.

It has been a tough year so far for Asian IPOs, even if the pricing last week of IHH Healthcare’s $2 billion offering did improve the data somewhat. A large number of deals have been pulled or postponed and, aside from the largest new listings Haitong Securities in Hong Kong, Felda Global Ventures in Malaysia and IHH in Malaysia and Singapore, many of the deals that have crossed the line have been bought primarily by corporate...